Company intelligence / Profile preview

BioMed News

Ownership: Private
Development stage: Other

Overview

BioMed News is a digital media and information services company dedicated to the life sciences, biotechnology, and pharmaceutical sectors. The platform serves as a news aggregator and reporting service, providing curated updates on clinical trial results, regulatory milestones, and scientific research breakthroughs. It caters to a global audience of healthcare professionals, researchers, and industry analysts by delivering timely insights into market trends and biomedical innovations. BioMed News operates primarily as an online portal, facilitating the dissemination of critical industry data and research summaries.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on BioMed News.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioMed News.

Explore the full profile